CYduct Diagnostics Inc (CYDX)

[zigzagman]

SNDY Completes Capital Restructuring Initiative

Solos Endoscopy, Inc. a provider of quality innovative healthcare instruments to hospitals across the country, is pleased to announce that the company has completed a capital restructuring initiative as part of a previously announced recapitalization plan in order to position itself for growth over the next twelve months. The restructuring involved a common stock consolidation that took effect September 23, 2015.

"The recapitalization is an effort by management to give the market an opportunity to recognize the true value of our company and rebuild shareholder value. Solos is a Company who has been recognized by physicians who use their instruments Nationwide. It is our hope that recognition will be shared by the market in the coming months," stated Robert Segersten, President Solos Endoscopy.

Solos Endoscopy instruments are FDA approved. Solos Endoscopy intends to carry the CE Mark on its entire MammoView(R) instrument line. Solos Endoscopy has posted its Certificate from TUV America on its website: http://www.solosendoscopy.com

http://old.barchart.com/headlines/story/11020469/solos-endoscopy-inc-completes-capital-restructuring-initiative